Paul B Manning - Net Worth and Insider Trading
Paul B Manning Net Worth
The estimated net worth of Paul B Manning is at least $648 Million dollars as of 2024-12-27. Paul B Manning is the Director, 10% Owner of Dova Pharmaceuticals Inc and owns about 14,762,242 shares of Dova Pharmaceuticals Inc (DOVA) stock worth over $414 Million. Paul B Manning is the Director of Liquidia Corp and owns about 6,582,192 shares of Liquidia Corp (LQDA) stock worth over $78 Million. Paul B Manning is also the Former 10% Owner of AveXis Inc and owns about 252,939 shares of AveXis Inc (AVXS) stock worth over $55 Million. Besides these, Paul B Manning also holds Taysha Gene Therapies Inc (TSHA) , Candel Therapeutics Inc (CADL) , Verrica Pharmaceuticals Inc (VRCA) , Acumen Pharmaceuticals Inc (ABOS) . Details can be seen in Paul B Manning's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Paul B Manning has not made any transactions after 2024-12-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Paul B Manning
Paul B Manning Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Paul B Manning owns 8 companies in total, including Taysha Gene Therapies Inc (TSHA) , Verrica Pharmaceuticals Inc (VRCA) , and Dova Pharmaceuticals Inc (DOVA) among others .
Click here to see the complete history of Paul B Manning’s form 4 insider trades.
Insider Ownership Summary of Paul B Manning
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TSHA | Taysha Gene Therapies Inc | 2024-06-27 | director & 10 percent owner |
| VRCA | Verrica Pharmaceuticals Inc | 2023-07-24 | director & 10 percent owner |
| DOVA | Dova Pharmaceuticals Inc | 2019-11-12 | director & 10 percent owner |
 | | 2018-05-15 | director & other: Former 10% Owner |
| | 2021-07-06 | 10 percent owner |
| | 2024-09-12 | director & 10 percent owner |
| | 2024-12-16 | director |
| | 2022-10-22 | 10 percent owner |
Paul B Manning Latest Holdings Summary
Paul B Manning currently owns a total of 7 stocks. Among these stocks, Paul B Manning owns 14,762,242 shares of Dova Pharmaceuticals Inc (DOVA) as of August 9, 2019, with a value of $414 Million and a weighting of 63.83%. Paul B Manning owns 6,582,192 shares of Liquidia Corp (LQDA) as of September 12, 2024, with a value of $78 Million and a weighting of 11.98%. Paul B Manning also owns 252,939 shares of AveXis Inc (AVXS) as of September 13, 2016, with a value of $55 Million and a weighting of 8.5%. The other 4 stocks Taysha Gene Therapies Inc (TSHA) , Candel Therapeutics Inc (CADL) , Verrica Pharmaceuticals Inc (VRCA) , Acumen Pharmaceuticals Inc (ABOS) have a combined weighting of 15.69% among all his current holdings.
Latest Holdings of Paul B Manning
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| DOVA | Dova Pharmaceuticals Inc | 2019-08-09 | 14,762,242 | 28.04 | 413,933,266 |
| LQDA | Liquidia Corp | 2024-09-12 | 6,582,192 | 11.80 | 77,669,866 |
| AVXS | AveXis Inc | 2016-09-13 | 252,939 | 217.83 | 55,097,702 |
| TSHA | Taysha Gene Therapies Inc | 2024-06-27 | 24,851,111 | 1.86 | 46,223,066 |
| CADL | Candel Therapeutics Inc | 2024-12-16 | 4,127,158 | 9.17 | 37,846,039 |
| VRCA | Verrica Pharmaceuticals Inc | 2023-07-24 | 15,589,481 | 0.65 | 10,112,896 |
| ABOS | Acumen Pharmaceuticals Inc | 2021-07-06 | 4,010,678 | 1.89 | 7,580,181 |
Holding Weightings of Paul B Manning
Paul B Manning Form 4 Trading Tracker
According to the SEC Form 4 filings, Paul B Manning has made a total of 0 transactions in Dova Pharmaceuticals Inc (DOVA) over the past 5 years. The most-recent trade in Dova Pharmaceuticals Inc is the acquisition of 28,062 shares on August 9, 2019, which cost Paul B Manning around $445,344.
According to the SEC Form 4 filings, Paul B Manning has made a total of 4 transactions in Liquidia Corp (LQDA) over the past 5 years, including 4 buys and 0 sells. The most-recent trade in Liquidia Corp is the acquisition of 337,078 shares on September 12, 2024, which cost Paul B Manning around $3 Million.
According to the SEC Form 4 filings, Paul B Manning has made a total of 0 transactions in AveXis Inc (AVXS) over the past 5 years. The most-recent trade in AveXis Inc is the sale of 289,855 shares on September 13, 2016, which brought Paul B Manning around $10 Million.
More details on Paul B Manning's insider transactions can be found in the Insider Trading History of Paul B Manning table.Insider Trading History of Paul B Manning
- 1
Paul B Manning Trading Performance
GuruFocus tracks the stock performance after each of Paul B Manning's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Paul B Manning is 4.42%. GuruFocus also compares Paul B Manning's trading performance to market benchmark return within the same time period. The performance of stocks bought by Paul B Manning within 3 months outperforms 12 times out of 34 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Paul B Manning's insider trading performs compared to the benchmark.
Performance of Paul B Manning
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 8.79 | | | | | |
| Relative Return to S&P 500(%) | 7.21 | | | | | |
Paul B Manning Ownership Network
Paul B Manning Owned Company Details
What does Taysha Gene Therapies Inc do?
Who are the key executives at Taysha Gene Therapies Inc?
Paul B Manning is the director & 10 percent owner of Taysha Gene Therapies Inc. Other key executives at Taysha Gene Therapies Inc include Chief Financial Officer Kamran Alam , 10 percent owner Session R.a. Ii , and 10 percent owner Astellas Pharma Inc. .
Taysha Gene Therapies Inc (TSHA) Insider Trades Summary
Over the past 18 months, Paul B Manning made 3 insider transaction in Taysha Gene Therapies Inc (TSHA) with a net purchase of 17,900,000. Other recent insider transactions involving Taysha Gene Therapies Inc (TSHA) include a net purchase of 777,778 shares made by Stalfort John A Iii , a net purchase of 444,444 shares made by Sean P. Nolan , and a net purchase of 111,111 shares made by Phillip B. Donenberg .
In summary, during the past 3 months, insiders sold 0 shares of Taysha Gene Therapies Inc (TSHA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 118,872 shares of Taysha Gene Therapies Inc (TSHA) were sold and 19,233,333 shares were bought by its insiders, resulting in a net purchase of 19,114,461 shares.
Taysha Gene Therapies Inc (TSHA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Taysha Gene Therapies Inc Insider Transactions
Paul B Manning Mailing Address
Above is the net worth, insider trading, and ownership report for Paul B Manning. You might contact Paul B Manning via mailing address: 200 Garrett Street Suite S, Charlottesville Va 22902.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
